ORIENT BIO Inc.

KOSE:A002630 Voorraadrapport

Marktkapitalisatie: ₩56.9b

ORIENT BIO Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jae-Jin Chang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.8%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Would ORIENT BIO (KRX:002630) Be Better Off With Less Debt?

May 01
Would ORIENT BIO (KRX:002630) Be Better Off With Less Debt?

Is ORIENT BIO (KRX:002630) Weighed On By Its Debt Load?

Jan 16
Is ORIENT BIO (KRX:002630) Weighed On By Its Debt Load?

CEO

Jae-Jin Chang (63 yo)

no data

Tenure

Mr. Jae-Jin Chang serves as the Chief Executive Officer of Bio Genomics, Inc. Mr. Chang serves as President, Chief Executive Officer and Chairperson of ORIENT BIO Inc. He completed graduate studies at Konk...